$MAZE
Maze Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$31.37
▼-1.75%-$0.560
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMaze Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is MAZE down today? It is at $31.37 (-1.75%), and our scanner flagged it 78 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MAZE spikes, and full due diligence on MAZE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MAZE 78 times in the last 30 days. Create a free account to track $MAZE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
MAZE is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on MAZE today, peaking at 4.4x its normal volume.
Likely catalystMaterial Agreement · Unregistered Share Sale, from an SEC filing. Read it →Latest filing144Notice of proposed insider sale (144)Oct 29, 2026 · todayA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
6,390,000 new shares · About $144.7M in size · Priced at $23.5/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bernstein Harold Officer | Sold (automatic/other) | -16K 0.03% of company | n/a | n/a | $435K at $26.93 | Oct 1, 26 |
Bernstein Harold Officer | Other | 16K 0.03% of company | n/a | 16K | $168K at $10.42 | Oct 1, 26 |
Coloma Jason V Officer | Sold (automatic/other) | -35K 0.06% of company | sold 14% | 207K | $932K at $27.02 | Oct 1, 26 |
Dandekar Atul Officer | Sold (automatic/other) | -8K 0.01% of company | sold 19% | 32K | $203K at $27.06 | Sep 29, 26 |
Dandekar Atul Officer | Other | 8K 0.01% of company | added 23% | 40K | $78K at $10.42 | Sep 29, 26 |
Bernstein Harold Officer | Sold (automatic/other) | -10K 0.02% of company | n/a | n/a | $254K at $26.22 | Sep 4, 26 |
Bernstein Harold Officer | Sold (automatic/other) | -5K | sold 35% | 10K | $134K at $25.78 | Sep 3, 26 |
Coloma Jason V Officer | Sold (automatic/other) | -11K 0.02% of company | sold 29% | 27K | $294K at $25.77 | Sep 3, 26 |
Dandekar Atul Officer | Sold (automatic/other) | -3K | sold 9.1% | 32K | $84K at $25.81 | Sep 3, 26 |
Courtney Phillips Officer | Sold (automatic/other) | -2K | sold 22% | 7K | $52K at $25.78 | Sep 3, 26 |
Bernstein Harold Officer | Sold (automatic/other) | -5K | sold 26% | 15K | $135K at $26.38 | Sep 2, 26 |
Coloma Jason V Officer | Sold (automatic/other) | -11K 0.02% of company | sold 22% | 39K | $296K at $26.38 | Sep 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
MAZE is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on MAZE today, peaking at 4.4x its normal volume.
MAZE last traded at $31.37, down 1.75% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Maze Therapeutics, Inc. Common Stock (MAZE) is next expected to report earnings on Thursday, November 5, 2026, about 6 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MAZE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MAZE 78 times in the last 30 days.
MAZE (Maze Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $1.77B in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MAZE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MAZE discussion
Sign in to ask a question or join the discussion.